Treatment with granulocyte-colony stimulating factor (G-CSF) promotes LLC and squamous carcinoma growth by promoting tumor angiogenesis, mediated by an increase in circulating endothelial progenitor cells and total MDSCs [9]. The gene discussed is CSF3; the disease is neoplasm.